Therefore, the current study aimed to determine the diagnostic and prognostic functions of FCRL1 and BAFF in Egyptian patients with diffuse large B-cell lymphoma (DLBCL), the most prevalent subtype of B-cell non-Hodgkin lymphoma. This evidence concerns the gene FCRL1 and B-cell non-Hodgkin lymphoma.